4//SEC Filing
Alkon Daniel L. 4
Accession 0001104659-20-130080
CIK 0001513856other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 5:09 PM ET
Size
5.9 KB
Accession
0001104659-20-130080
Insider Transaction Report
Form 4
Neurotrope, Inc.NTRP
Alkon Daniel L.
President
Transactions
- Award
Stock Option (right to buy)
2020-11-24+40,000→ 40,000 totalExercise: $0.97Exp: 2030-11-24→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares will immediately vest and become exercisable subject to and upon consummation of (1) the merger of PM Merger Sub 1, LLC with and into Metuchen Pharmaceuticals, LLC ("Metuchen"), with Metuchen surviving as a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. ("Petros") and (2) the merger of PN Merger Sub 2, Inc. with and into Neurotrope, Inc. ("Neurotrope"), with Neurotrope surviving as a wholly-owned subsidiary of Petros.
Documents
Issuer
Neurotrope, Inc.
CIK 0001513856
Entity typeother
Related Parties
1- filerCIK 0001686138
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 5:09 PM ET
- Size
- 5.9 KB